NASDAQ · VVORX
Invesco Value Opportunities R
$26.88-$0.25 (-0.92%)
Invesco Value Opportunities R’s quoted price sits in the upper half of its reported 52-week range, 5.82% below the high.
Loading market information…
NASDAQ · FSPHX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Fidelity Select Health Care Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fidelity Select Health Care Portfolio’s forward annual dividend is $6.15 per share, paid semi-annual. The forward yield is 19.9% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund, known as Fidelity Select Health Care Portfolio (FSPHX), primarily focuses its investments within the medical and healthcare industries. It allocates a substantial majority—at least 80%—of its total assets to companies actively involved in the creation, production, or distribution of goods and services integral to health and medicine. The portfolio predominantly holds equity shares, including those from both U.S. and international firms. Investment selections are made through a meticulous fundamental analysis process, evaluating aspects such as each company's financial health, its competitive position within its sector, and the broader economic and market environments. It's classified as a non-diversified fund, indicating a potentially more concentrated portfolio than diversified funds.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 12:49 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$26.88-$0.25 (-0.92%)
Invesco Value Opportunities R’s quoted price sits in the upper half of its reported 52-week range, 5.82% below the high.
$41.90-$1.21 (-2.81%)
DFA Emerging Markets Portfolio I’s quoted price sits in the lower half of its reported 52-week range, 14.24% below the high.
$75.63-$1.06 (-1.38%)
Permanent Portfolio Permanent I’s quoted price sits in the lower half of its reported 52-week range, 9.63% below the high.
$69.38+$0.29 (+0.42%)
BlackRock Health Sciences Opportunities Portfolio Service Shares’s quoted price sits in the upper half of its reported 52-week range, 1.22% below the high.
$76.04+$0.32 (+0.42%)
BlackRock Health Sciences Opportunities Portfolio Class K’s quoted price sits in the upper half of its reported 52-week range, 0.28% below the high.
$75.78+$0.31 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Institutional Shares’s quoted price sits in the upper half of its reported 52-week range, 0.33% below the high.
$65.52+$0.26 (+0.4%)
BlackRock Health Sciences Opportunities Portfolio’s quoted price sits in the upper half of its reported 52-week range, 1.87% below the high.
$68.92+$0.28 (+0.41%)
BlackRock Health Sciences Opportunities Portfolio Investor A Shares’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
